CATHERINE GEIGER: Open Payments
NPI 1518651363 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,262 in 153 payments from 26 companies in 2025. Trend: 2023 $775 · 2024 $3,058 · 2025 $3,262
Food & beverage: $3,053Consulting: $150Education: $60
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $472 |
| GENZYME CORPORATION | 18 | $384 |
| GlaxoSmithKline, LLC. | 28 | $377 |
| Regeneron Healthcare Solutions, Inc. | 17 | $340 |
| JAZZ PHARMACEUTICALS INC. | 6 | $289 |
| United Therapeutics Corporation | 7 | $180 |
| Insmed, Inc. | 10 | $175 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $145 |
| ANI Pharmaceuticals, Inc. | 5 | $104 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $95 |
Products named: DUPIXENT, XYWAV, FASENRA, NUCALA, Tyvaso, Arikayce, TRELEGY ELLIPTA, TEZSPIRE.
Industry payments across NC — which companies pay providers there.
